A Study of Pertuzumab in Participants With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Pertuzumab
Sponsor: Hoffmann-La Roche